Hedley, S.J., Chen, J., Mountz, J.D., Li, J., Curiel, D.T., Korokhov, N., and Kovesdi, I. (2006). Targeted and shielded adenovectors for cancer therapy. Cancer Immunol Immunother, 55(11), 1412-1419.

Hedley, S.J., Auf der Maur, A., Hohn, S., Escher, D., Barberis, A., Glasgow, J.N., Douglas, J.T., Korokhov, N., and Curiel, D.T. (2006). An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery. Gene Ther, 13(1), 88-94.

Noureddini, S.C., Krendelshchikov, A., Simonenko, V., Hedley, S.J., Douglas, J.T., Curiel, D.T., and Korokhov, N. (2006). Generation and selection of targeted adenoviruses embodying optimized vector properties. Virus Res, 116(1-2), 185-195.

Breidenbach, M., Rein, D.T., Everts, M., Glasgow, J.N., Wang, M., Passineau, M.J., Alvarez, R.D., Korokhov, N., and Curiel, D.T. (2005). Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy. Gene Ther, 12(2), 187-193.

Everts, M., Kim-Park, S.A., Preuss, M.A., Passineau, M.J., Glasgow, J.N., Pereboev, A.V., Mahasreshti, P.J., Grizzle, W.E., Reynolds, P.N., and Curiel, D.T. (2005). Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors. Gene Ther, 12(13), 1042-1048.

Hosokawa, M., Kadota, R., Shichijo, S., Itoh, K., Dmitriev, I., Krasnykh, V., Curiel, D.T., Takue, Y., Wakasugi, H., Takashima, S., and Heike, Y. (2005). Cell cycle arrest and apoptosis induced by SART-1 gene transduction. Anticancer Res, 25(3B), 1983-1990.

Korokhov, N., de Gruijl, T.D., Aldrich, W.A., Triozzi, P.L., Banerjee, P.T., Gillies, S.D., Curiel, T.J., Douglas, J.T., Scheper, R.J., and Curiel, D.T. (2005). High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN. Cancer Biol Ther, 4(3), 289-294.

Korokhov, N., Noureddini, S.C., Curiel, D.T., Santegoets, S.J., Scheper, R.J., and de Gruijl, T.D. (2005). A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system. Mol Pharm, 2(3), 218-223.

Noureddini, S.C., and Curiel, D.T. (2005). Genetic targeting strategies for adenovirus. Mol Pharm, 2(5), 341-347.

Ono, H.A., Davydova, J.G., Adachi, Y., Takayama, K., Barker, S.D., Reynolds, P.N., Krasnykh, V.N., Kunisaki, C., Shimada, H., Curiel, D.T., and Yamamoto, M. (2005). Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer. J Gastroenterol, 40(1), 31-42.

Tsuruta, Y., Pereboeva, L., Glasgow, J.N., Luongo, C.L., Komarova, S., Kawakami, Y., and Curiel, D.T. (2005). Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway. Biochem Biophys Res Commun, 335(1), 205-214.

Wang, M., Hemminki, A., Siegal, G.P., Barnes, M.N., Dmitriev, I., Krasnykh, V., Liu, B., Curiel, D.T., and Alvarez, R.D. (2005). Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery. Gynecol Oncol, 96(2), 341-348.

Glasgow, J.N., Bauerschmitz, G.J., Curiel, D.T., and Hemminki, A. (2004). Transductional and transcriptional targeting of adenovirus for clinical applications. Curr Gene Ther, 4(1), 1-14.

Grandi, P., Wang, S., Schuback, D., Krasnykh, V., Spear, M., Curiel, D.T., Manservigi, R., and Breakefield, X.O. (2004). HSV-1 virions engineered for specific binding to cell surface receptors. Mol Ther, 9(3), 419-427.

Rivera, A.A., Wang, M., Suzuki, K., Uil, T.G., Krasnykh, V., Curiel, D.T., and Nettelbeck, D.M. (2004). Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo. Virology, 320(1), 121-134.

Timares, L., Douglas, J.T., Tillman, B.W., Krasnykh, V., and Curiel, D.T. (2004). Adenovirus-mediated gene delivery to dendritic cells. Methods Mol Biol, 246, 139-154.

Belousova, N., Korokhov, N., Krendelshchikova, V., Simonenko, V., Mikheeva, G., Triozzi, P.L., Aldrich, W.A., Banerjee, P.T., Gillies, S.D., Curiel, D.T., and Krasnykh, V. (2003). Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol, 77(21), 11367-11377.

Korokhov, N., Mikheeva, G., Krendelshchikov, A., Belousova, N., Simonenko, V., Krendelshchikova, V., Pereboev, A., Kotov, A., Kotova, O., Triozzi, P.L., Aldrich, W.A., Douglas, J.T., Lo, K.M., Banerjee, P.T., Gillies, S.D., Curiel, D.T., and Krasnykh, V. (2003). Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J Virol, 77(24), 12931-12940.

Pereboeva, L., Komarova, S., Mikheeva, G., Krasnykh, V., and Curiel, D.T. (2003). Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells, 21(4), 389-404.

Takayama, K., Reynolds, P.N., Short, J.J., Kawakami, Y., Adachi, Y., Glasgow, J.N., Rots, M.G., Krasnykh, V., Douglas, J.T., and Curiel, D.T. (2003). A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology, 309(2), 282-293.

Yamamoto, M., Davydova, J., Wang, M., Siegal, G.P., Krasnykh, V., Vickers, S.M., and Curiel, D.T. (2003). Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology, 125(4), 1203-1218.

Belousova, N., Krendelchtchikova, V., Curiel, D.T., and Krasnykh, V. (2002). Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol, 76(17), 8621-8631.

Haviv, Y.S., Blackwell, J.L., Kanerva, A., Nagi, P., Krasnykh, V., Dmitriev, I., Wang, M., Naito, S., Lei, X., Hemminki, A., Carey, D., and Curiel, D.T. (2002). Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res, 62(15), 4273-4281.

Haviv, Y.S., Takayama, K., Glasgow, J.N., Blackwell, J.L., Wang, M., Lei, X., and Curiel, D.T. (2002). A model system for the design of armed replicating adenoviruses using p53 as a candidate transgene. Mol Cancer Ther, 1(5), 321-328.

Sullivan, D.E., Mondelli, M.U., Curiel, D.T., Krasnykh, V., Mikheeva, G., Gaglio, P., Morris, C.B., Dash, S., and Gerber, M.A. (2002). Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein. J Hepatol, 37(5), 660-668.

Asada-Mikami, R., Heike, Y., Kanai, S., Azuma, M., Shirakawa, K., Takaue, Y., Krasnykh, V., Curiel, D.T., Terada, M., Abe, T., and Wakasugi, H. (2001). Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells. Jpn J Cancer Res, 92(3), 321-327.

Cripe, T.P., Dunphy, E.J., Holub, A.D., Saini, A., Vasi, N.H., Mahller, Y.Y., Collins, M.H., Snyder, J.D., Krasnykh, V., Curiel, D.T., Wickham, T.J., DeGregori, J., Bergelson, J.M., and Currier, M.A. (2001). Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Cancer Res, 61(7), 2953-2960.

Krasnykh, V., Belousova, N., Korokhov, N., Mikheeva, G., and Curiel, D.T. (2001). Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol, 75(9), 4176-4183.

Suzuki, K., Fueyo, J., Krasnykh, V., Reynolds, P.N., Curiel, D.T., and Alemany, R. (2001). A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. Clin Cancer Res, 7(1), 120-126.